Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank100
3Y CAGR+102.1%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

3Y CAGR
+102.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
8.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$18.99M+57.2%
2024$12.09M+113.0%
2023$-92.93M-4137.1%
2022$2.30M+102.6%
2021$-87.93M-58.3%
2020$-55.54M-0.7%
2019$-55.18M-83.6%
2018$-30.05M-39.4%
2017$-21.56M-27.2%
2016$-16.95M-